Data availability
Not applicable.
References
Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296–1304. https://doi.org/10.1136/annrheumdis-2019-215213
Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, De Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RHWM, De Groot PGD, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris J-C, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74:1011–1018. https://doi.org/10.1136/annrheumdis-2013-204838
Khairani CD, Bejjani A, Piazza G, Jimenez D, Monreal M, Chatterjee S, Pengo V, Woller SC, Cortes-Hernandez J, Connors JM, Kanthi Y, Krumholz HM, Middeldorp S, Falanga A, Cushman M, Goldhaber SZ, Garcia DA, Bikdeli B (2023) Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol 81:16–30. https://doi.org/10.1016/j.jacc.2022.10.008
Giarretta I, Ageno W, Dentali F (2022) Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome. Haematologica 107:2737–2741. https://doi.org/10.3324/haematol.2022.281586
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
Several authors received honoraria, consulting fees and research support from several firms who may have an interest in the results of this meta-analysis. However, given that the conclusion of the meta-analysis favors VKAs, it is unlikely that conflicts of interests had any relevance.
Ethical Statements such as Human and animal rights statement and Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sircana, M.C., Crisci, G., Giardino, F. et al. Antiphospholipid syndrome: are old school VKAs still the best choice?. Intern Emerg Med 19, 217–219 (2024). https://doi.org/10.1007/s11739-023-03482-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-023-03482-7